The novel FluoMag-dCoDe platform enables mRNA and protein quantification in blood, improving diagnostic accuracy.
Simultaneous quantification of multiple biomarker classes from blood is essential for improving diagnostic accuracy, yet current methods remain limited by low multiplexing capacity, reliance on separate instruments and workflows, and inconsistent signal readouts that hinder data integration. Here, we present FluoMag-dCoDe (Fluorescence-coded, Magnetic bead-enhanced digital Co-Detection of multi-analytes), a unified platform that converts diverse analytes into distinct fluorescence-coded DNA templates for multiplexed quantification in a single digital PCR (dPCR) reaction using a universal primer and TaqMan probe set. We demonstrate co-measurement of eight mRNA and three protein immune-response biomarkers in a two-color dPCR format. The platform achieves high quantitative fidelity with minimal cross-interference, showing strong concordance with single-plex RT-qPCR for mRNAs and superior analytical sensitivity to ELISA for proteins – including reliable detection of TRAIL where ELISA failed – from ~ 35 μL fingerstick-compatible blood volumes. By unifying mRNA and protein quantification in a single standardized readout while sustaining robust performance from low blood volumes, FluoMag-dCoDe establishes a scalable approach for high-dimensional biomarker analysis in precision diagnostics.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: